Walvax Biotechnology Co., Ltd. (SHE:300142)
China flag China · Delayed Price · Currency is CNY
11.71
+0.04 (0.34%)
At close: Dec 5, 2025

Walvax Biotechnology Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2019 - 2015
Cash & Equivalents
1,6813,7644,3653,8733,4431,962
Upgrade
Cash & Short-Term Investments
1,6813,7644,3653,8733,4431,962
Upgrade
Cash Growth
-53.59%-13.77%12.68%12.49%75.54%-17.62%
Upgrade
Accounts Receivable
2,2842,4103,1013,5772,4812,004
Upgrade
Other Receivables
394.2258.8114.18416.13774.86304.77
Upgrade
Receivables
2,6782,4683,2153,9933,2552,308
Upgrade
Inventory
545752.591,035995.81873.59483.56
Upgrade
Other Current Assets
1,00882.22119.2186.25107.9426.77
Upgrade
Total Current Assets
5,9127,0678,7338,9487,6804,780
Upgrade
Property, Plant & Equipment
4,0424,0793,7683,1612,6041,590
Upgrade
Long-Term Investments
984.991,6381,0571,2921,4911,605
Upgrade
Goodwill
33.6633.6633.6633.6633.6633.66
Upgrade
Other Intangible Assets
858.231,0351,0861,167434.98271.68
Upgrade
Long-Term Accounts Receivable
3.67.27----
Upgrade
Long-Term Deferred Tax Assets
103.84104.56103.44124.84168.01138.55
Upgrade
Long-Term Deferred Charges
555.89513.86473.48309.381,022890
Upgrade
Other Long-Term Assets
756.93246.62333.54300.2240.63329.41
Upgrade
Total Assets
13,25214,72415,58915,33613,6749,638
Upgrade
Accounts Payable
1,3381,5681,8051,8361,258607.79
Upgrade
Accrued Expenses
30.2549.81722.051,145754.71497.41
Upgrade
Short-Term Debt
--320.2797.1831040
Upgrade
Current Portion of Long-Term Debt
18.638.988.79---
Upgrade
Current Portion of Leases
-7.8521.8823.354.6-
Upgrade
Current Income Taxes Payable
23.53-14.1319.472.0368.54
Upgrade
Current Unearned Revenue
28.47106.18160.47192.9635.299.68
Upgrade
Other Current Liabilities
239.7899.4151.25194.15870.61198.55
Upgrade
Total Current Liabilities
1,6782,3703,2043,5093,2351,422
Upgrade
Long-Term Debt
234433.34434.9314.24--
Upgrade
Long-Term Leases
19.6511.7720.627.741.06-
Upgrade
Long-Term Unearned Revenue
256.65278.44423.33404.53344.3256.18
Upgrade
Long-Term Deferred Tax Liabilities
65.5455.9168.7190.9494.56112.27
Upgrade
Other Long-Term Liabilities
54.46742.08---
Upgrade
Total Liabilities
2,3093,2164,1944,3463,6751,790
Upgrade
Common Stock
1,5991,5991,6071,6071,6011,546
Upgrade
Additional Paid-In Capital
4,5494,5494,9004,9654,7723,262
Upgrade
Retained Earnings
3,2573,1102,9842,5801,8951,546
Upgrade
Treasury Stock
---358.63-286.42--
Upgrade
Comprehensive Income & Other
277.53171.28217.18217.18216.33190.88
Upgrade
Total Common Equity
9,6839,4309,3499,0848,4846,545
Upgrade
Minority Interest
1,2602,0782,0461,9061,5151,303
Upgrade
Shareholders' Equity
10,94311,50811,39510,9909,9997,848
Upgrade
Total Liabilities & Equity
13,25214,72415,58915,33613,6749,638
Upgrade
Total Debt
272.24491.94806.42462.51315.6740
Upgrade
Net Cash (Debt)
1,4093,2723,5583,4113,1281,922
Upgrade
Net Cash Growth
-51.37%-8.05%4.31%9.06%62.77%-19.30%
Upgrade
Net Cash Per Share
0.882.052.222.131.991.23
Upgrade
Filing Date Shares Outstanding
1,5991,5991,5991,6011,6011,546
Upgrade
Total Common Shares Outstanding
1,5991,5991,5991,6011,6011,546
Upgrade
Working Capital
4,2344,6975,5295,4404,4453,358
Upgrade
Book Value Per Share
6.055.905.855.675.304.23
Upgrade
Tangible Book Value
8,7918,3618,2307,8838,0166,239
Upgrade
Tangible Book Value Per Share
5.505.235.154.925.014.04
Upgrade
Buildings
-953.95948.5767.91541.68487.84
Upgrade
Machinery
-2,1962,0931,5801,235930.76
Upgrade
Construction In Progress
-2,1141,6451,5091,527762.51
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.